Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16e1432f31c8183a134a4ba04b6443a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af5978c465dc99fa57524ae217ad798f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00351 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2090-3614 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2576-023 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0044 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B1-043 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B90-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-02028 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0084 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B90-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-00 |
filingDate |
2021-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35710c1344eca5ee7ca81fc37b930bbc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0619376040b15c9fa0f6958371191ea8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8ce74ac9e0a246541f1725ea3d021de http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a4cee1a82f3f8059bbccd5f00113811 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_879ec1eb5d02d897716ee5a44a7b8fe7 |
publicationDate |
2022-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2022142482-A1 |
titleOfInvention |
Systems and Methods for Determining Lesion Depth Using Fluorescence Imaging |
abstract |
Systems, catheter and methods for treating Atrial Fibrillation (AF) are provided, which are configure to illuminate a heart tissue having a lesion site; obtain a mitochondrial nicotinamide adenine dinucleotide hydrogen (NADH) fluorescence intensity from the illuminated heart tissue along a first line across the lesion site; create a 2-dimensional (2D) map of the depth of the lesion site along the first line based on the NADH fluorescence intensity; and determine a depth of the lesion site at a selected point along the first line from the 2D map, wherein a lower NADH fluorescence intensity corresponds to a greater depth in the lesion site and a higher NADH fluorescence intensity corresponds to an unablated tissue. The process may be repeated to create a 3 dimensional map of the depth of the lesion. |
priorityDate |
2013-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |